Recent research has highlighted the role of CTHRC1, a secreted protein involved in ECM and tissue remodeling, as a biomarker for lung fibrosis and coexpressed proteins as a marker for disease diagnosis and the monitoring of pirfenidone treatment [17,18,19,20]. The gene discussed is CTHRC1; the disease is pulmonary fibrosis.